UK adds E coli to mandatory HAI surveillance programme
This article was originally published in Clinica
Executive Summary
The UK’s Department of Health is to extend the mandatory surveillance of healthcare-associated infections (HAIs) in England to include Escherichia coli (E coli) bacteraemias, as of 1 June 2011. The government is expecting rapid “comprehensive compliance” of case identification and reporting, according to a letter sent by chief medical officer Dame Sally Davies and deputy NHS chief executive David Flory to hospital managers. New guidelines are being drawn up by the DH and the Health Protection Agency (HPA) specifically for the surveillance of E coli, the letter notes.
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.